Showing results (51-60 of 68) with videos related to
Sort By:
Pageof 7
Cell Reports|April 18, 2025
The low-dose CHK1 inhibitor prexasertib triggers VDAC1 dephosphorylation to activate mtDNA-STING signaling and synergize immunotherapyYu Fu, Xiaoyan Kang, Wenting Li, et al.Aging|December 4, 2021
Impact of chemotherapy and immunotherapy on the composition and function of immune cells in COVID-19 convalescent with gynecological tumorsTianyu Qin, Ensong Guo, Funian Lu, et al.The Journal of Experimental Medicine|November 26, 2021
WEE1 inhibition induces anti-tumor immunity by activating ERV and the dsRNA pathwayEnsong Guo, Rourou Xiao, Yifan Wu, et al.Journal for Immunotherapy of Cancer|April 18, 2023
BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumorsYu Fu, Bin Yang, Yaoyuan Cui, et al.Translational Oncology|July 7, 2022
Evaluation of the prognostic value of lymphadenectomy for low-grade serous ovarian cancer: A case-control multicenter retrospective studyZhongshao Chen, Ran Chu, Yuanming Shen, et al.Nature Communications|June 10, 2021
Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infectionBin Yang, Junpeng Fan, Jia Huang, et al.Annals of Internal Medicine|December 7, 2020
Dynamics and Correlation Among Viral Positivity, Seroconversion, and Disease Severity in COVID-19 : A Retrospective StudyYu Fu, Yongsheng Li, Ensong Guo, et al.Cell Reports. Medicine|July 10, 2024
Genomic profiling of a multi-lineage and multi-passage patient-derived xenograft biobank reflects heterogeneity of ovarian cancerTianyu Qin, Zhe Hu, Li Zhang, et al.Nature Genetics|November 21, 2023
Multiomic analysis of cervical squamous cell carcinoma identifies cellular ecosystems with biological and clinical relevanceJunpeng Fan, Funian Lu, Tianyu Qin, et al.Science Translational Medicine|March 12, 2025
Heterogeneous cellular responses to hyperthermia support combined intraperitoneal hyperthermic immunotherapy for ovarian cancer mouse modelsXingyuan Hu, Xiaoyan Kang, Faming Zhao, et al.Pageof 7